AMRZ

Value Q2, 25Q3, 25Q4, 25 TTM Total revenue 3.22 B3.67 B— — Gross profit 966 M1.09 B— — Operating expenses 223 M230 M156 M — Selling/general/admin expenses 299 M312 M— — Research & development ——— — Operating income 669 M778 M-156 M — Non-Operating Income, Total 23 M5 M— — Interest expense, net of interest capitalized 143 M94 M— — Non-Operating Income, excl. Interest Expenses -121 M-89 M— — Unusual income/expense 1 M0— — Pretax income 550 M693 M1.5 B — Equity in earnings 1 M4 M— — Taxes 122 M150 M175 M — Non-controlling/minority interest 1 M2 M— — After tax other income/expense ——— — Net income before discontinued operations 429 M545 M1.32 B — Discontinued operations ——— — Net income 429 M545 M1.32 B — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 429 M545 M1.32 B — Basic earnings per share (Basic EPS) 0.780.99— — Diluted earnings per share (Diluted EPS) 0.780.982.39 — Average basic shares outstanding 553.1 M553.1 M553.1 M — Diluted shares outstanding 553.1 M553.9 M553.6 M — EBITDA 925 M1.05 B— — EBIT 743 M856 M— — Cost of revenue 2.25 B2.59 B— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 182 M192 M142 M —